Read about this biopharm company here
China is in a catch 22 position now - on one hand , the government is pumping in money to support the High Tech industries like Ecommerce, automation, Electric Vehicles, RFID, Robotics, AI, etc and on the other hand, they know that they are faced with an aging population.
The latter will hit its supply chain hard as more...
